Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00114413 · ClinicalTrials.gov registry record · NA
Evaluation of an Asthma Treatment Strategy Based on Exhaled Nitric Oxide Measurements in Adolescents
A NA study of Asthma, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- NA
- Development phase
- 547
- Enrollment target
- 12
- Study locations
NCT00114413: Completed NA study of Asthma, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT00114413 is a NA study of Asthma that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 547 participants, below the 1,562-participant average among 374 other Asthma trials with a reported enrollment target (65% lower). The trial reports 12 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00114413, a NA study of Asthma, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- NA
- Development phase
- 547 participants
- Enrollment target
- 12
- Study locations
Study Summary
The purpose of ICAC-01 is to determine whether an asthma treatment strategy that measures exhaled nitric oxide (eNO) to indicate disease progression is more effective in treating asthma symptoms when combined with existing asthma treatment guidelines than treatment using the guidelines alone.
Conditions Studied
Interventions
- DRUG Inhaled corticosteroids
- PROCEDURE eNO measurement
Study Locations (12)
Arizona
- University of Arizona (DAIT-ICAC-01/02) - Tucson
Colorado
- National Jewish Medical and Research Center (DAIT-ICAC-01/02) - Denver
District of Columbia
- Howard University - Washington D.C.
Illinois
- Children's Memorial Hospital - Chicago
Maryland
- Johns Hopkins University - Baltimore
Massachusetts
- Boston University School of Medicine - Boston
Missouri
- Washington University School of Medicine - St Louis
New York
- Mount Sinai (DAIT-ICAC-01/02) - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 547 participants |
| Start Date | 2004-08 |
| Est. Completion | 2006-11 |
| Phase | NA |
What the finished NCT00114413 record still lists
NCT00114413 is an interventional study that assigns participants to a tested intervention. The registered 547 participants enrollment target is mid-sized for trials with a published cap, below the 1,562-participant average among 374 other Asthma trials with a reported enrollment target (65% lower).
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which Inhaled corticosteroids is the first listed.
NCT00114413 lists 12 locations in 12 states (Arizona, Colorado, District of Columbia).
Frequently Asked Questions
What is clinical trial NCT00114413 about?
NCT00114413 is a clinical study titled "Evaluation of an Asthma Treatment Strategy Based on Exhaled Nitric Oxide Measurements in Adolescents". The purpose of ICAC-01 is to determine whether an asthma treatment strategy that measures exhaled nitric oxide (eNO) to indicate disease progression is more effective in treating asthma symptoms when combined with existing asthma treatment guidelines than treatment using the guidelines alone.
What is the current status of trial NCT00114413?
This trial is currently completed. It is a NA study. The enrollment target is 547 participants. The study started on 2004-08. Estimated completion is 2006-11.
What conditions does trial NCT00114413 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT00114413?
The interventions under investigation include: Inhaled corticosteroids (DRUG), eNO measurement (PROCEDURE).
Who is sponsoring clinical trial NCT00114413?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00114413 being conducted?
This trial has 12 study locations across Arizona, Colorado, District of Columbia, Illinois, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00114413's enrollment target sits among peer trials
547 75th of 374 higher than 300 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
ASTHMAXcel Voice Study
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Asthma and Technology in Emerging African American Adults
RECRUITING · NA
-
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03572374 · 546 participants · NA
Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job
- NCT05937685 · 546 participants · NA
Reducing Blood Pressure in Patients With High Cardiovascular Risk
- NCT06416150 · 546 participants · NA
Reducing Urban Cervical Cancer Disparities
- NCT06850922 · 546 participants · Phase 1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia